Junpeng Huang
Key Laboratory Of Laboratory Medical Diagnostics
Chongqing, 400016, China
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2024
Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells.
Journal: International journal of molecular sciences
Published: November 23, 2022
Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia.
Journal: Frontiers in oncology
Published: August 31, 2022
Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia.
Journal: Cell death & disease
Published: July 19, 2022
Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis.
Journal: Frontiers in oncology
Published: November 18, 2021
miR-148b-3p inhibits the proliferation and autophagy of acute myeloid leukemia cells by targeting ATG14
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: October 21, 2021
Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
Journal: Journal of extracellular vesicles
Published: July 04, 2021
Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 02, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026